CMPX

Compass Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) · SIC 2836CIK 1738021Held by 5 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

5 managers · Q2 2026 13F

13F bookWeight

Vivo Capital

Vivo CapitalPosition history →

1.6%

(18.7%)

$17.0M

$1.10B13F book · 2026-06-30

Suvretta Capital Management

Suvretta Capital ManagementPosition history →

0.65%

(1.4%)

$30.9M

$4.76B13F book · 2026-06-30

OrbiMed Advisors

OrbiMed AdvisorsPosition history →

0.63%

—

$33.3M

$5.25B13F book · 2026-06-30

Royce & Associates

Royce & AssociatesPosition history →

0.02%

(17.5%)

$2.9M

$12.42B13F book · 2026-06-30

Adage Capital Management

Adage Capital ManagementPosition history →

<0.01%

(86.0%)

$2.6M

$71.32B13F book · 2026-06-30

Weight = position value ÷ the manager's total 13F long-equity value in the same filing — one definition for every row. “1st obs.” marks a position with no earlier stored 13F to compare against — it is not shown as a purchase.